Ruxia Han

2.0k total citations
31 papers, 1.7k citations indexed

About

Ruxia Han is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Ruxia Han has authored 31 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Biomedical Engineering, 9 papers in Biomaterials and 8 papers in Molecular Biology. Recurrent topics in Ruxia Han's work include Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (7 papers) and Immunotherapy and Immune Responses (7 papers). Ruxia Han is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (7 papers) and Immunotherapy and Immune Responses (7 papers). Ruxia Han collaborates with scholars based in China and United Kingdom. Ruxia Han's co-authors include Zhiyong Qian, Ying Hao, Jinrong Peng, Kun Shi, Xinlong He, Jinfeng Liao, Yongzhi Wu, Chengli Yang, Qingya Liu and Yuwen Chen and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and Chemical Engineering Journal.

In The Last Decade

Ruxia Han

30 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruxia Han China 20 1.1k 511 427 372 241 31 1.7k
Rangrang Fan China 26 928 0.8× 774 1.5× 444 1.0× 524 1.4× 170 0.7× 72 2.0k
Yanpeng Jia China 19 1.0k 0.9× 525 1.0× 303 0.7× 371 1.0× 125 0.5× 33 1.7k
Chuanhui Song China 24 1.0k 0.9× 277 0.5× 606 1.4× 483 1.3× 252 1.0× 46 1.8k
Shaojun Peng China 27 1.5k 1.3× 885 1.7× 561 1.3× 674 1.8× 227 0.9× 47 2.4k
Zhaoxu Tu China 20 1.1k 1.0× 555 1.1× 541 1.3× 637 1.7× 164 0.7× 51 2.0k
Nicholas Thomas Blum China 26 1.6k 1.4× 570 1.1× 843 2.0× 416 1.1× 231 1.0× 33 2.1k
Caina Xu China 24 1.2k 1.1× 553 1.1× 732 1.7× 695 1.9× 236 1.0× 33 2.0k
Nansha Gao China 19 978 0.9× 703 1.4× 474 1.1× 452 1.2× 128 0.5× 25 1.6k

Countries citing papers authored by Ruxia Han

Since Specialization
Citations

This map shows the geographic impact of Ruxia Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruxia Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruxia Han more than expected).

Fields of papers citing papers by Ruxia Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruxia Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruxia Han. The network helps show where Ruxia Han may publish in the future.

Co-authorship network of co-authors of Ruxia Han

This figure shows the co-authorship network connecting the top 25 collaborators of Ruxia Han. A scholar is included among the top collaborators of Ruxia Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruxia Han. Ruxia Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Rui, Hao Dun, Lihua Xu, et al.. (2025). Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer. Biomedicines. 13(4). 882–882. 1 indexed citations
2.
Luo, Tianzhi, Ruxia Han, Kun Shi, et al.. (2025). NIR-driven GOx-like nanozyme-modified injectable thermoresponsive hydrogel for antibacterial therapy and bone regeneration in periodontitis. Chemical Engineering Journal. 506. 160108–160108. 12 indexed citations
3.
Gou, Shanshan, Xu Liu, Mengyu Li, et al.. (2025). Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway. Materials Today Bio. 32. 101826–101826. 2 indexed citations
4.
Lv, Guangyao, et al.. (2025). Membrane-based biomimetic delivery systems for glioblastoma multiforme therapy. Nanotechnology Reviews. 14(1).
5.
Wang, Rui, Xibin Wang, Hao Dun, et al.. (2025). GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer. Frontiers in Immunology. 15. 1506632–1506632. 6 indexed citations
6.
Han, Ruxia, Bing Han, Huaiyu Zhou, et al.. (2024). Anti-Toxoplasma gondii effect of tylosin in vitro and in vivo. Parasites & Vectors. 17(1). 59–59. 5 indexed citations
7.
Han, Ruxia, et al.. (2024). Cinnamaldehyde: Pharmacokinetics, anticancer properties and therapeutic potential (Review). Molecular Medicine Reports. 30(3). 7 indexed citations
8.
Cheng, Shuang, Meng Pan, Danrong Hu, et al.. (2023). Adhesive chitosan-based hydrogel assisted with photothermal antibacterial property to prompt mice infected skin wound healing. Chinese Chemical Letters. 34(12). 108276–108276. 38 indexed citations
10.
Hao, Ying, Yuwen Chen, Xinlong He, et al.. (2022). RGD peptide modified platinum nanozyme Co-loaded glutathione-responsive prodrug nanoparticles for enhanced chemo-photodynamic bladder cancer therapy. Biomaterials. 293. 121975–121975. 63 indexed citations
13.
Han, Ruxia, Qingya Liu, Yi Lu, et al.. (2021). Tumor microenvironment-responsive Ag2S-PAsp(DOX)-cRGD nanoparticles-mediated photochemotherapy enhances the immune response to tumor therapy. Biomaterials. 281. 121328–121328. 51 indexed citations
14.
Liao, Jinfeng, Ruxia Han, Yongzhi Wu, & Zhiyong Qian. (2021). Review of a new bone tumor therapy strategy based on bifunctional biomaterials. Bone Research. 9(1). 18–18. 186 indexed citations
15.
Han, Ruxia, Zhejun Xu, Chun‐Xue Zhou, et al.. (2021). Upregulation of lncRNA147410.3 in the Brain of Mice With Chronic Toxoplasma Infection Promoted Microglia Apoptosis by Regulating Hoxb3. Frontiers in Cellular Neuroscience. 15. 648047–648047. 4 indexed citations
16.
Peng, Jinrong, Yao Xiao, Qian Yang, et al.. (2020). Intracellular aggregation of peptide-reprogrammed small molecule nanoassemblies enhances cancer chemotherapy and combinatorial immunotherapy. Acta Pharmaceutica Sinica B. 11(4). 1069–1082. 27 indexed citations
17.
Han, Ruxia, Yao Xiao, Qian Yang, et al.. (2020). Ag2S nanoparticle-mediated multiple ablations reinvigorates the immune response for enhanced cancer photo-immunotherapy. Biomaterials. 264. 120451–120451. 69 indexed citations
18.
Xiao, Yao, Jinrong Peng, Qingya Liu, et al.. (2020). Ultrasmall CuS@BSA nanoparticles with mild photothermal conversion synergistically induce MSCs-differentiated fibroblast and improve skin regeneration. Theranostics. 10(4). 1500–1513. 82 indexed citations
19.
Yang, Qian, Jinrong Peng, Kun Shi, et al.. (2019). Rationally designed peptide-conjugated gold/platinum nanosystem with active tumor-targeting for enhancing tumor photothermal-immunotherapy. Journal of Controlled Release. 308. 29–43. 96 indexed citations
20.
Peng, Jinrong, Qian Yang, Yao Xiao, et al.. (2019). Tumor Microenvironment Responsive Drug‐Dye‐Peptide Nanoassembly for Enhanced Tumor‐Targeting, Penetration, and Photo‐Chemo‐Immunotherapy. Advanced Functional Materials. 29(19). 121 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026